Elite Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent
Elite Pharmaceuticals, Inc. (ELTP) had Operating Lease, Liability, Noncurrent of $870.59 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $870.59K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $1.02M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $1.16M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $1.29M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $870.59K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.02M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $1.16M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.29M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.42M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.55M 10-K · filed 2026-06-29 |
| 2024-12-31 | $1.68M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $1.74M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.85M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.96M 10-K · filed 2025-06-30 |
| 2022-09-30 | $2.16K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $782.23K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $835.89K 10-K · filed 2023-06-29 |
| 2021-12-31 | $933.54K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $939.62K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $38.87K 10-K · filed 2022-06-29 |
| 2020-09-30 | $56.54K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $112.24K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $167.11K 10-K · filed 2021-06-14 |
| 2019-12-31 | $221.17K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $273.31K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $324.68K 10-Q · filed 2019-08-09 |